In the Netherlands, Bedrocan's bankruptcy delays medical cannabis reform
Published
In the Netherlands, the bankruptcy of the company Bedrocan continues to disrupt the medical cannabis market. Bedrocan is a well-known company in this sector. It produces cannabis intended for medical use, under strict control.
According to a note from the Dutch government dated 26 October 2026, this situation has consequences for the planned reform. The reform timetable is therefore being postponed. The available information does not yet give all the details of the planned changes.
Medical cannabis is used in several European countries to treat certain illnesses, under the supervision of health authorities. In this context, the decisions taken by the Netherlands are being followed by other countries that are considering their own arrangements.
The Dutch government has not yet announced a new specific date for the reform. The next steps remain to be confirmed in the coming weeks.
Sources: Newsweed
More France news
- Maxime Pavageau, 29, wins France's best young wine seller title
- A New, Highly Promising Concrete
- Paris and Île-de-France: Immersive Exhibitions to Experience Art Differently
- France 3 broadcasts a documentary on the history of the Téléthon, narrated by Zazie
- ChatGPT launches business profiles with mention and click statistics
- Trail: France Outdoor Seeks to Frame Environmental Restrictions
- A Roanne company bets on knitwear made in France
- Sport: Major Win for the Brûleurs de Loups and Six Internationals Absent for FC Annecy